{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T04:46:49Z","timestamp":1648788409104},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[1981,7,1]],"date-time":"1981-07-01T00:00:00Z","timestamp":362793600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"published-print":{"date-parts":[[1981,7]]},"DOI":"10.1007\/bf03349445","type":"journal-article","created":{"date-parts":[[2014,4,9]],"date-time":"2014-04-09T03:34:24Z","timestamp":1397014464000},"page":"281-287","source":"Crossref","is-referenced-by-count":3,"title":["The 24-h urinary cyclic adenosine 3\u2032, 5\u2032-monophosphate\/creatinine ratio: an useful approach to the diagnosis of parathyroid disorders and function"],"prefix":"10.1007","volume":"4","author":[{"given":"A.","family":"Caniggia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Nuti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Galli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,4,4]]},"reference":[{"key":"BF03349445_CR1","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1126\/science.159.3814.545","volume":"159","author":"IR Chase","year":"1968","unstructured":"Chase I.R., Aurbach G.D. Renal adenyl-cyclase: anatomically separate sites for parathyroid hormone and vasopressin. Science 159: 545, 1968.","journal-title":"Science"},{"key":"BF03349445_CR2","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1073\/pnas.58.2.518","volume":"58","author":"IR Chase","year":"1967","unstructured":"Chase I.R., Aurbach G.D. Parathyroid function and the renal excretion of 3\u2032, 5\u2032 - adenylic acid. Prac. Natl. Acad. Sci. (USA) 58: 518, 1967.","journal-title":"Prac. Natl. Acad. Sci. (USA)"},{"key":"BF03349445_CR3","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1172\/JCI106458","volume":"49","author":"NI Kaminsky","year":"1970","unstructured":"Kaminsky N.I., Broadus A.E., Hardman J.G., Jones D.J. Jr., Ball J.H., Sutherland E.W., Liddle G.W. Effect of parathyroid hormone on plasma and urinary adenosine 3\u2032, 5\u2032 -monophosphate in man. J. Clin. Invest. 49: 2387, 1970.","journal-title":"J. Clin. Invest."},{"key":"BF03349445_CR4","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1530\/acta.0.0770282","volume":"77","author":"MT Scurry","year":"1974","unstructured":"Scurry M.T., Pauk G.L Renal tubular localisation of parathyroid hormone induced urinary cyclic adenosine 3\u2032, 5\u2032 -monophosphate. Acta Endocrinol. (Kbh.) 77: 282, 1974.","journal-title":"Acta Endocrinol. (Kbh.)"},{"key":"BF03349445_CR5","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1056\/NEJM197206292862604","volume":"286","author":"F Murad","year":"1972","unstructured":"Murad F., Pak C.Y.CT Urinary excretion of adenosine 3\u2032, 5\u2032 -monophosphate and guanosine 3\u2032, 5\u2032 -monophospate in man. N. Engl. J. Med. 286: 1382, 1972.","journal-title":"N. Engl. J. Med."},{"key":"BF03349445_CR6","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1210\/jcem-35-6-775","volume":"35","author":"PH Dohan","year":"1972","unstructured":"Dohan P.H., Yamashita K., Larsen P.R., David B., Deftos L, Field J.B. Evaluation of urinary cyclic 3\u2032, 5\u2032 -adenosine monophosphate excretion in the differential diagnosis of hypercalcaemia. J. Clin. Endocrinol. Metab. 35: 775, 1972.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BF03349445_CR7","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1172\/JCI108611","volume":"59","author":"JW Shaw","year":"1977","unstructured":"Shaw J.W., Oldham S.B., Rosoff L, Bethung J.E., Fichman M.P. Urinary cyclic AMP analysed as a function of the serum calcium and parathyroid hormone in the differential diagnosis of hypercalcaemia. J. Clin. Invest. 59: 14. 1977.","journal-title":"J. Clin. Invest."},{"key":"BF03349445_CR8","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/0026-0495(76)90018-4","volume":"25","author":"MK Drezner","year":"1976","unstructured":"Drezner M.K., Neelon F.A., Curtis H.B., Lebovitz H.E. Renal cyclic adenosine monophosphate an accurate index of parathyroid function. Metabolism 25: 1103, 1976.","journal-title":"Metabolism"},{"key":"BF03349445_CR9","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1172\/JCI106441","volume":"49","author":"AE Broadus","year":"1970","unstructured":"Broadus A.E., Kaminsky N.I., Hardman J.C., Sutherland E.W., Liddle G.W. Kinetic parameters and renal clearances of plasma adenosine 3\u2032, 5\u2032 -monophosphate and guanosine 3\u2032, 5\u2032 -monophosphate in man. J. Clin. Invest. 49: 2222, 1970.","journal-title":"J. Clin. Invest."},{"key":"BF03349445_CR10","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1172\/JCI108831","volume":"60","author":"AE Broadus","year":"1977","unstructured":"Broadus A.E., Mahaffey Y.E., Bartter F.C., Neer R.M. Nephrogenous cyclic adenosine monophosphate as a parathyroid function test. J. Clin. Invest. 60: 771, 1977.","journal-title":"J. Clin. Invest."},{"key":"BF03349445_CR11","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S0140-6736(73)92199-5","volume":"7","author":"FA Neelon","year":"1973","unstructured":"Neelon F.A., Drezner M., Birch B.M., Lebovitz H.E. Urinary cyclic adenosine monophosphate an aid in the diagnosis of hyperparathyroidism. Lancet 7: 631, 1973.","journal-title":"Lancet"},{"key":"BF03349445_CR12","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1172\/JCI107774","volume":"54","author":"CYC Pak","year":"1974","unstructured":"Pak C.Y.C., Ohata M., Lawrence E.C., Snyder W. The hypercalciuria causes, parathyroid functions, and diagnositc criteria. J. Clin. Invest. 54: 387, 1974.","journal-title":"J. Clin. Invest."},{"key":"BF03349445_CR13","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/j.1365-2265.1979.tb03079.x","volume":"11","author":"T Onishi","year":"1979","unstructured":"Onishi T., Tsuji M., Morimoto S., Okada Y., Arima M., Itatani H., Kinoshita K., Sonoda T., Kumahara Y. Changes of urinary cyclic AMP excretion and plasma parathyroid hormone levels before and after parathyroidectomy in patients with primary hyperpar athyroidism. Clin. Endocrinol. (Oxf.) 11: 307, 1979.","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"BF03349445_CR14","first-page":"49","volume-title":"Osteoporosis II","author":"LV Avioli","year":"1979","unstructured":"Avioli L.V., Baran D.T., Whyte M.P., Teitelbaum S.L The biochemical and skeletal heterogeneity of \u00abpost menopausal osteoporosis\u00bb. In: Barzel U.S. (Ed.), Osteoporosis II. Grune and Stratton, New York, 1979, p. 49."},{"key":"BF03349445_CR15","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S0021-9258(18)84756-1","volume":"66","author":"CH Fiske","year":"1925","unstructured":"Fiske C.H., Subbarow Y. The colorimetric determination of phosphorus. J. Biol. Chem. 66: 375, 1925.","journal-title":"J. Biol. Chem."},{"key":"BF03349445_CR16","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1093\/oxfordjournals.bmb.a074335","volume":"9","author":"EJ King","year":"1953","unstructured":"King E.J. Plasma alkaline phospatase in disease. Br. Med. Bull. 9: 160, 1953.","journal-title":"Br. Med. Bull."},{"key":"BF03349445_CR17","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0021-9258(19)51149-8","volume":"184","author":"RE Neuman","year":"1950","unstructured":"Neuman R.E., Logan M.A. The determination of hydroxyproline. J. Biol. Chem. 184: 299, 1950.","journal-title":"J. Biol. Chem."},{"key":"BF03349445_CR18","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1136\/jcp.29.1.69","volume":"29","author":"C Gennari","year":"1976","unstructured":"Gennari C, Galli M. Montagnani M. Urinary cyclic adenosine. monophosphate in young adults and elderly subjects. J. Clin. Pathol. 29: 69, 1976.","journal-title":"J. Clin. Pathol."},{"key":"BF03349445_CR19","volume-title":"Human cyclic AMP assays","author":"M Galli","year":"1980","unstructured":"Galli M., Nuti R., Campagna M.S., Franci B. Human cyclic AMP assays. Proceedings of 2nd international symposium on recent advances of radioimmunoassay. Clinical apllications of parathyroid hormone, calcitonin, vitamin D. Taormina, March 8\u20139, 1980. In press."},{"key":"BF03349445_CR20","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/222797a0","volume":"222","author":"DH Marshall","year":"1969","unstructured":"Marshall D.H., Nordin B.E.C. Kinetic analysis of plasma radioactivity after oral ingestion of radiocalcium. Nature 222: 797, 1969.","journal-title":"Nature"},{"key":"BF03349445_CR21","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1136\/bmj.1.5432.427","volume":"7","author":"A Caniggia","year":"1965","unstructured":"Caniggia A., Gennari C, Cesari L. Intestinal absorption of 45calcium in stone forming patients. Br. Med. J. 7: 427, 1965.","journal-title":"Br. Med. J."},{"key":"BF03349445_CR22","first-page":"355","volume":"3","author":"F Murad","year":"1973","unstructured":"Murad F. Clinical studies and application of cyclic nucleotides. Adv. Cyclic. Nucleotide Res. 3: 355, 1973.","journal-title":"Adv. Cyclic. Nucleotide Res."},{"key":"BF03349445_CR23","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/0002-9343(78)90453-9","volume":"64","author":"CY Pak","year":"1978","unstructured":"Pak C.Y, Fetner C, Townsend J., Brinkley L, North- cutt C, Barilla D.E., Kadesky M., Peters P. Evaluation of calcium urolithiasis in ambulatory pa tients. Am. J. Med. 64: 979, 1978.","journal-title":"Am. J. Med."},{"key":"BF03349445_CR24","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1172\/JCI107156","volume":"52","author":"FL Coe","year":"1973","unstructured":"Coe F.L, Canterbury J.M., Firpo J.J., Reiss E. Evidence for secondary hyperparathyroidism idiopatic hypercalciuria. J. Clin. Invest. 52: 134, 1973.","journal-title":"J. Clin. Invest."},{"key":"BF03349445_CR25","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1515\/9783112330029-051","volume-title":"Vitamin D, basic research and its clinical application","author":"AD Care","year":"1979","unstructured":"Care A.D., Pickard D.W., Papapoulus S.E., d\u2019Riordan J.L.H., Garel J.M., Redel J. The interactions between vitamin D metabolites, parathyroid hormone and calcitonin. In: Norman A.W., Schaefer K., v. Herrath D., Grigoleit H.G., Coburn J.W., De Luca H.F., Mawer E.B., Suda T. (Eds.), Vitamin D, basic research and its clinical application. De Gruyter, Berlin, 1979, p. 289."},{"key":"BF03349445_CR26","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1073\/pnas.65.2.446","volume":"65","author":"F Murad","year":"1970","unstructured":"Murad F., Brewer H.B., Vaughan M. Effect of thyrocalcitonin on adenosine 3\u2032, 5\u2032 -cyclic phosphate formation by rat kidney and bone. Proc. Natl. Acad. Sci. (USA) 65: 446, 1970.","journal-title":"Proc. Natl. Acad. Sci. (USA)"},{"key":"BF03349445_CR27","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/BF02546409","volume":"20","author":"A Caniggia","year":"1976","unstructured":"Caniggia A., Gennari C, Vattimo A., Nardi P., Nuti R., Galli M. Early effects of synthetic bovine parathyroid hormone and synthetic salmon calcitonin on urinary excretion of cyclic AMP, phosphate and calcium in man. Calcif. Tissue Res. 20: 209, 1976.","journal-title":"Calcif. Tissue Res."},{"key":"BF03349445_CR28","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1365-2362.1980.tb02067.x","volume":"10","author":"A Caniggia","year":"1980","unstructured":"Caniggia A., Gennari C, Lore F., Galli M., Nuti R. Effects of parathyroid hormone and calcitonin on plasma and urinary adenosine 3\u2032, 5\u2032 -monophosphate in man. Eur. J. Clin. Invest. 10: 89, 1980.","journal-title":"Eur. J. Clin. Invest."},{"key":"BF03349445_CR29","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1111\/j.0954-6820.1963.tb17445.x","volume":"173","author":"A Caniggia","year":"1963","unstructured":"Caniggia A., Gennari C. Bianchi V., Guideri R. Intestinal absorption of 45Ca in senile osteoporosis. Acta Med. Scand. 173: 613, 1963.","journal-title":"Acta Med. Scand."},{"key":"BF03349445_CR30","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1042\/cs0380397","volume":"38","author":"A Caniggia","year":"1970","unstructured":"Caniggia A., Gennari C., Bencini M., Cesari L., Bor-rello G. Calcium metabolism and 47calcium kinetics before and after long-term thyrocalcitonin treatment in senile osteoporosis. Clin. Sci. 38: 397, 1970.","journal-title":"Clin. Sci."},{"key":"BF03349445_CR31","first-page":"558","volume":"22","author":"S Wallach","year":"1977","unstructured":"Wallach S., Cohn S.H., Atkins H.L, Ellis K.J., Kohberger R., Aloia J.F., Zanzi I. Effect of salmon calcitonin on skeletal mass in osteoporosis. Therap. Res. 22: 558, 1977.","journal-title":"Therap. Res."},{"key":"BF03349445_CR32","first-page":"135","volume-title":"Osteoporosis II","author":"CH Chesnut","year":"1979","unstructured":"Chesnut C.H., Ivey J.L, Nelp W.B., Baylink D.J. Assessment of anabolic steroids and calcitonin in the treatment of osteoporosis. In: Barzel U.S. (Ed.), Osteoporosis II. Grune and Stratton, New York, 1979, p. 135."},{"key":"BF03349445_CR33","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/S0140-6736(76)92216-9","volume":"1","author":"J Reeve","year":"1976","unstructured":"Reeve J., Hesp R., Williams D., Hulme P., Klenerman L., Zanelli J.M., Darby A.J., Tregear G.W., Parsons J.A. Anabolic effect of low doses of a fragment of human parathyroid hormone on the skeleton in post menopausal osteoporosis. Lancet 1: 1035, 1976.","journal-title":"Lancet"},{"key":"BF03349445_CR34","first-page":"151","volume-title":"Osteoporosis II","author":"JA Parson","year":"1979","unstructured":"Parson J.A., Bernat M., Bijvoet O.L.M., Meunier P.J., Neer R.M., Potts J.T. Jr., Reeve J., Renier J.C., Slovik D., Vismans J. Low doses of a synthetic fragment of human parathyroid hormone (hPTH 1-34) as a stimulus to bone formation. In: Barzel U.S. (Ed.), Osteoporosis II. Grune and Stratton, New York, 1979, p. 151."}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03349445.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF03349445\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03349445","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T04:12:09Z","timestamp":1648786329000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF03349445"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1981,7]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1981,7]]}},"alternative-id":["BF03349445"],"URL":"https:\/\/doi.org\/10.1007\/bf03349445","relation":{},"ISSN":["0391-4097","1720-8386"],"issn-type":[{"value":"0391-4097","type":"print"},{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[1981,7]]}}}